Table 5 Vital signs responsible for alterations in clinical rule scores
Clinical rule | Alteration** | n | Responsible vital sign(s)*** | |||||
|---|---|---|---|---|---|---|---|---|
SBP | HR | RR | GCS | T | SpO2 | |||
qSOFA | Deterioration | 105 | 59 (56.2%) | 52 (49.5%) | 15 (14.4%) | |||
Improvement | 120 | 58 (48.3%) | 73 (60.8%) | 23 (19.3%) | ||||
Total | 225 | 117 (52.0%) | 125 (55.6%) | 38 (17.0%) | ||||
SIRS | Deterioration | 203 | 61 (30.0%) | 98 (48.3%) | 83 (40.9%) | |||
Improvement | 272 | 82 (30.1%) | 118 (43.3%) | 132 (48.5%) | ||||
Total | 475 | 143 (30.1%) | 216 (45.5%) | 215 (45.3%) | ||||
MEWS | Deterioration | 160 | 39 (24.4%) | 52 (32.5%) | 87 (54.4%) | 1 (0.6%) | 52 (32.5%) | |
Improvement | 211 | 40 (19.0%) | 62 (29.4%) | 102 (48.3%) | 3 (1.4%) | 107 (50.7%) | ||
Total | 371 | 79 (21.3%) | 114 (30.7%) | 189 (50.9%) | 4 (1.1%) | 159 (42.9%) | ||
NEWS | Deterioration | 243 | 95 (39.1%) | 67 (27.6%) | 135 (55.6%) | 4 (1.6%) | 43 (17.7%) | 117 (48.1%) |
Improvement | 279 | 113 (40.5%) | 84 (30.1%) | 149 (53.4%) | 4 (1.4%) | 80 (28.7%) | 143 (51.3%) | |
Total | 522 | 208 (39.8%) | 151 (28.9%) | 284 (54.4%) | 8 (1.5%) | 123 (23.6%) | 260 (49.8%) | |